Baylor College of Medicine et al. vs The Board of Regents of the University of Texas System et al.

Termination Decision Document

Ex. 3001

Petitioner's and Patent Owner's Joint Motion to Terminate Inter Partes Review Proceedings Pursuant to 35 U.S.C. �� 317(A)

[BUSINESS CONFIDENTIAL INFORMATION] Patent Assignment Agreement [executed]

[BUSINESS CONFIDENTIAL INFORMATION] Amendment to Patent Assignment Agreement [executed]

Petitioner's and Patent Owner's Joint Request to File Agreements as Business Confidential Information Pursuant to 35 U.S.C. �� 317

Patent Owner's Updated Exhibit List

Patent Owner's Notice of Appeal

Granting Patent Owner's Motion to Stay 37 C.F.R. sec. 42.5

Petitioner's Response to Patent Owner's Motion to Stay

Patent Owner's Unopposed Motion to Stay

Denying Patent Owners Motion to Dismiss 37 C.F.R. sec 42.5

Patent Owner's Reply to Petitioner's Response to Patent Owner's Motion to Dismiss

Petitioners Response to Patent Owners Motion to Dismiss

Patent Owner's Motion to Dismiss

Conduct of the Proceeding

Conduct of the Proceeding 37 C.F.R. sec. 42.5

Unopposed Motion for Olin R. Hebert III to Appear Pro Hac Vice

Declaration of Olin R. Hebert III in Support of Motion to Appear Pro Hac Vice

Patent Owner's Mandatory Notices

Power of Attorney Pursuant to 37 C.F.R. Sec. 42.10(b)

NOTICE OF FILING DATE ACCORDED TO PETITION AND TIME FOR FILING PATENT OWNER PRELIMINARY RESPONSE

PETITION FOR INTER PARTES REVIEW OF CLAIMS 1-29 OF U.S. PATENT NO. 9,333,248

Prosecution History for U.S. Patent No. 9,333,248

Eggert et al., "Chapter 12-Generation of human and murine dendritic cells," in Cell Biology: A Laboratory Handbook, 3d ed. 2006

U.S. Patent No. 9,333,248

Giboa et al., "DC-based cancer vaccines," The Journal of Clinical Investigation

WO2007/067782 to Boynton et al.

Decker et al. "Double loading of dendritic cell MHC class I and MHC class II with an AML antigen repertoire enhances correlates of T-cell community in vitro via amplification of T-cell help," Vaccine (2006)

CV of Dr. Laura Santambrogio

Expert Declaration of Dr. Laura Santambrogio

Zeng et al., "Generation of NY-ESO-1-specific CD4+ and CD8+ T cells by a single peptide with dual MHC class I and class II specificities: a new strategy for vaccine design," Cancer Research (2002)

Molldrem et al., "Targeted T-cell therapy for human leukemia: cytotoxic T lymphocytes specific for a peptide derived from proteinase 3 preferentially lyse human myeloid leukemia cells," Blood (1996)

Ballieux et al., "Cell-mediated autoimmunity in patients with Wegener's granulomatosis (WG)," Clinical & Experimental Immunology (1995)

Winek et al., "Frequency of proteinase 3 (PR3)-specific autoreactive T cells determined by cytokine flow cytometry in Wegener's granulomatosis," Journal of Autoimmunity (2004)

Tedder et al., "Isolation and generation of human dendritic cells," Current Protocols in Immunology (1997)

U.S. Patent No. 6,645,487

U.S. Patent No. 7,264,810

Lotem et al., "Presentation of tumor antigens by dendritic cells genetically modified with viral and nonviral vectors," Journal of Immunotherapy (2006)

U.S. Patent Application No. 2006/0073123

Ossendorp et al., "Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors," Journal of Experimental Medicine (1998)

Bachinsky et al., "Mapping and binding analysis of peptides derived from the tumor-associated antigen survivin for eight HLA alleles," Cancer Immunotherapy (2005)

Schmidt et al., "Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cells," Immunobiology (2003)

Decker et al., "Cell-autonomous upregulation of dendritic cell immunocompetence is antigen-dependent," Blood (2005)

U.S. Patent No. 6,107,023

U.S. Patent No. 6,960,449

Gensetix, Inc., et al. v. Baylor College of Medicine, et al., No. 4:17-cv-01025-LPS, Dkt. No. 46

Fissolo et al., "Naturally presented peptides on major histocompatibility complex I and II molecules eluted from central nervous system of multiple sclerosis patients," Molecular & Cellular Proteomics (2009)

Expert Declaration of Sylvia Hall-Ellis, Ph.D.

Chen et al., "A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening," PNAS (1997)

Supplementary Tables of Fissolo et al., "Naturally presented peptides on major histocompatibility complex I and II molecules eluted from central nervous system of multiple sclerosis patients," Molecular & Cellular Proteomics (2009)

Power of Attorney